FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in New York, United States

Biotech startups in New York, United States

Updated 16 Nov 2026

Reset
Biotech startups in New York, United States
One-time CSV
  • 350 funded companies, 286 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~new-york-united-states.csv350 rows × 18 columns
CompanyCityLast roundAmountDate
PathosNew YorkSeries E$237.0M2026-10-23
EvvyNew YorkSeries B$40.0M2026-09-15
OpentronsLong Island CitySeries E$40.0M2026-10-29
Massive BioNew YorkSeries B$17.0M2022-06-02
BiotiaLong Island CitySeries A$9.0M2026-10-01
GametoNew YorkSeries C$44.0M2025-08-12
Waypoint BioNew YorkSeries A$20.0M2026-05-27
Glyphic BiotechnologiesNew YorkSeries A$38.0M2025-09-26

8 rows of the CSV in 5 of its 18 columns.

350
Startups
$10.3B
Total raised
55
Funded in the last 12 months
$1.3B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

28 of 350
28 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Opentrons Unicorn Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. Artificial intelligence Long Island City Series E $40.0M 2026-10-29 $300.2M Y Combinator, SOSV, Khosla Ventures +2 251 to 500 2014
Pathos Pathos is a biotechnology company that uses AI to speed up oncology drug development. Artificial intelligence New York Series E $237.0M 2026-10-23 $684.0M New Enterprise Associates, Lightbank, Builders VC +1 11 to 50 2022
Biotia Biotia is a health tech startup that offers AI solutions to diagnose and control infectious diseases. Artificial intelligence Long Island City Series A $9.0M 2026-10-01 $19.7M Everywhere Ventures, Sand Hill Angels, Tau Ventures +2 11 to 50 2016
Evvy Evvy offers an AI-driven precision medicine platform focused on women's health. Artificial intelligence New York Series B $40.0M 2026-09-15 $59.0M General Catalyst, BoxGroup, Left Lane Capital +2 11 to 50 2021
heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
ElectroKare ElectroKare builds computational models that simulate human physiological systems and processes. Artificial intelligence New York Seed $4.0M 2026-07-01 $4.0M iVenture Accelerator, Techstars Physical Health, Fort Worth, Texas 11 to 50 2025
Kimba Kimba uses AI to analyze biometric data and deliver personalized scent treatments for better sleep and health. Artificial intelligence New York Seed $5.4M 2026-06-16 $6.4M Techstars 1 to 10 2024
Waypoint Bio Waypoint Bio applies spatial biology to improve cell therapy development. Artificial intelligence New York Series A $20.0M 2026-05-27 $34.5M Village Global, Fifty Years, Hummingbird Ventures +2 11 to 50 2021
Century Health Century Health applies AI to real-world clinical data to accelerate drug development and commercialization. Artificial intelligence New York Seed $5.0M 2026-05-19 $7.0M Alumni Ventures, Everywhere Ventures, 2048 Ventures +1 1 to 10 2023
Click Therapeutics Click Therapeutics develops and commercializes software-based prescription treatments for unmet healthcare needs. Biotech New York Series D $50.0M 2026-04-09 $1.1B Silicon Valley Bank, Accelmed, HSBC Innovation Banking +1 101 to 250 2012
Gilgamesh Pharmaceuticals Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. Biotech New York Series A $60.0M 2026-03-24 $142.6M Y Combinator, Alumni Ventures, Gaingels +2 11 to 50 2019
OncoPrecision OncoPrecision develops patient-centric therapeutic antibodies. Biotech New York Seed $4.5M 2025-11-24 $11.1M SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL +2 11 to 50 2020
Helex Helex works on making gene editing safer. Biotech New York Seed $3.5M 2025-10-30 $4.6M SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2021
Gameto Gameto develops cell-engineered therapeutics for the female reproductive system. Biotech New York Series C $44.0M 2025-08-12 $117.0M FJ Labs, Insight Partners, Gaingels +2 11 to 50 2020
Argon AI Argon AI automates life sciences activities in clinical and commercial settings. Artificial intelligence New York Seed $5.5M 2025-07-02 $11.5M Y Combinator, Pioneer Fund, Eight Capital 1 to 10 2023
TMRW Life Sciences TMRW Life Sciences manages cryospecimens with automated, software-guided platforms. Biotech New York Series D $28.2M 2024-07-12 $181.7M Google Ventures, Casdin Capital, 5AM Ventures 51 to 100 2018
Formation Bio Unicorn Formation Bio is a drug development company that aims to speed treatments to patients by reimagining clinical trials. Artificial intelligence New York Series D $372.0M 2024-06-26 $528.0M Andreessen Horowitz, Sequoia Capital, Thrive Capital +1 101 to 250 2013
EvolutionaryScale EvolutionaryScale develops biological AI models for therapeutic design. Artificial intelligence New York Seed $142.0M 2024-06-25 $142.0M Lux Capital, NVentures 11 to 50 2023
Auxilius Auxilius provides financial management software for clinical trials in biopharma. Biotech Brooklyn Series A $10.0M 2024-03-15 $20.0M Bain Capital Ventures, SignalFire, XYZ Venture Capital +1 11 to 50 2020
BioNeex BioNeex runs an open R&D exchange and marketplace connecting biotech and biopharmaceutical companies directly. Biotech Syracuse Seed $500K 2024-02-15 $1.0M BANA Angels 11 to 50 2018
Carez AI Carez AI builds vision models designed to perform reliably in real-world conditions. Artificial intelligence New York Pre-seed $150K 2024-01-08 $150K (ERA) Entrepreneurs Roundtable Accelerator 1 to 10 2024
Native AI Native AI provides an always-on market intelligence platform for understanding customers and creating better experiences. Artificial intelligence New York Seed $3.5M 2023-04-06 $5.7M Capital Innovators, Connetic Ventures, IvyCap Ventures +2 11 to 50 2018
Massive Bio Massive Bio runs an AI oncology platform that matches patients with clinical trials and gives pharma companies access to them. Artificial intelligence New York Series B $17.0M 2022-06-02 $23.8M 500 Global, 500 Emerging Europe, KFW DEG 101 to 250 2015
Immunai Unicorn Immunai applies machine learning and software engineering to map and reprogram immunology. Artificial intelligence New York Series B $215.0M 2021-10-27 $295.0M 8VC, TLV Partners, Alexandria Venture Investments +2 101 to 250 2018
Flextrapower Flextrapower is a remote-monitoring company powered by graphene technology. Biotech New York Seed $120K 2019-07-15 $1.2M Techstars, MassChallenge, National Science Foundation +2 11 to 50 2015
Pymetrics Pymetrics develops neuroscience-based assessment technology that predicts candidate fit for staffing firms. Artificial intelligence New York Series B $40.0M 2018-09-27 $56.6M MassChallenge, Khosla Ventures, Salesforce Ventures +2 101 to 250 2011
Zpoken AI Zpoken AI is a data science company focused on cognitive solutions. Artificial intelligence New York Seed $130K 2017-02-01 $130K Starta VC, Starta Accelerator 11 to 50 2016
Case Case makes a GSM-enabled, biometrically protected multi-signature hardware wallet for securing digital assets. Biotech Rochester Seed $1.0M 2015-09-10 $2.2M RRE Ventures, Third Kind Venture Capital, Flight Ventures +1 11 to 50 2014

Table 1. Biotech startups in New York, United States: the 28 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 350.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Pathos Pathos is a biotechnology company that uses AI to speed up oncology drug development. Artificial intelligence New York Series E $237.0M 2026-10-23 $684.0M New Enterprise Associates, Lightbank, Builders VC +1 11 to 50 2022
2 Gilgamesh Pharmaceuticals Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company developing psychedelic drugs to treat mental illness. Biotech New York Series A $60.0M 2026-03-24 $142.6M Y Combinator, Alumni Ventures, Gaingels +2 11 to 50 2019
3 Click Therapeutics Click Therapeutics develops and commercializes software-based prescription treatments for unmet healthcare needs. Biotech New York Series D $50.0M 2026-04-09 $1.1B Silicon Valley Bank, Accelmed, HSBC Innovation Banking +1 101 to 250 2012
4 Opentrons Unicorn Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. Artificial intelligence Long Island City Series E $40.0M 2026-10-29 $300.2M Y Combinator, SOSV, Khosla Ventures +2 251 to 500 2014
5 Evvy Evvy offers an AI-driven precision medicine platform focused on women's health. Artificial intelligence New York Series B $40.0M 2026-09-15 $59.0M General Catalyst, BoxGroup, Left Lane Capital +2 11 to 50 2021
6 Waypoint Bio Waypoint Bio applies spatial biology to improve cell therapy development. Artificial intelligence New York Series A $20.0M 2026-05-27 $34.5M Village Global, Fifty Years, Hummingbird Ventures +2 11 to 50 2021
7 heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
8 Biotia Biotia is a health tech startup that offers AI solutions to diagnose and control infectious diseases. Artificial intelligence Long Island City Series A $9.0M 2026-10-01 $19.7M Everywhere Ventures, Sand Hill Angels, Tau Ventures +2 11 to 50 2016
9 Kimba Kimba uses AI to analyze biometric data and deliver personalized scent treatments for better sleep and health. Artificial intelligence New York Seed $5.4M 2026-06-16 $6.4M Techstars 1 to 10 2024
10 Century Health Century Health applies AI to real-world clinical data to accelerate drug development and commercialization. Artificial intelligence New York Seed $5.0M 2026-05-19 $7.0M Alumni Ventures, Everywhere Ventures, 2048 Ventures +1 1 to 10 2023

Table 2. Biotech startups in New York, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 SOSV Venture capital firm Princeton, United States 7 2% 3 Opentrons, heXem bio, OncoPrecision
2 Alumni Ventures Angel group Manchester, United States 7 2% 2 Century Health, Gilgamesh Pharmaceuticals
3 Y Combinator Startup accelerator Mountain View, United States 6 2% 2 Opentrons, Gilgamesh Pharmaceuticals
4 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 6 2% 2 heXem bio, OncoPrecision
5 Catalio Capital Management Venture capital firm New York, United States 4 1%
6 Gaingels Syndicate Burlington, United States 3 1% 1 Gilgamesh Pharmaceuticals
7 Pioneer Fund Startup accelerator Toronto, Canada 3 1% 1 Gilgamesh Pharmaceuticals
8 Andreessen Horowitz Venture capital firm Menlo Park, United States 3 1%
9 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 1%
10 Techstars Startup accelerator New York, United States 3 1% 1 Kimba
11 BoxGroup Venture capital firm New York, United States 2 1% 1 Evvy
12 Khosla Ventures Venture capital firm Menlo Park, United States 2 1% 1 Opentrons
13 Everywhere Ventures Venture capital firm New York, United States 2 1% 2 Biotia, Century Health
14 RA Capital Management Startup incubator Boston, United States 2 1%
15 National Institutes of Health Entrepreneurship program Bethesda, United States 2 1%

Table 3. Biotech startups in New York, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 271 77% $9.4B
Software 86 25% $3.7B
Artificial intelligence 67 19% $3.0B
Hardware 15 4% $432.8M
Fintech 9 3% $18.1M
Energy 5 1% $18.9M
Education 4 1% $78.4M
Cybersecurity 3 1% $31.2M
Commerce 1 0%

Table 4. Biotech startups in New York, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 36 10% $400K
Seed 178 51% $1.8M
Series A 81 23% $20.0M
Series B 32 9% $36.0M
Series C 9 3% $75.0M
Series D+ 14 4% $40.0M

Table 5. Biotech startups in New York, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
New York 263 75%
Brooklyn 20 6%
Rochester 9 3%
Ithaca 7 2%
Syracuse 5 1%
Buffalo 5 1%
Stony Brook 3 1%
Long Island City 2 1%
White Plains 2 1%
Troy 2 1%
Tarrytown 2 1%
Bedford 1 0%

Table 6. Biotech startups in New York, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 6 11% $290.0M
September 2026 6 11% $132.8M
August 2026 2 4% $3.5M
July 2026 2 4% $5.5M
June 2026 4 7% $31.0M
May 2026 6 11% $81.0M
April 2026 4 7% $97.0M
March 2026 3 5% $110.0M
February 2026 3 5% $116.5M
January 2026 8 15% $245.1M
December 2025 7 13% $151.8M
November 2025 4 7% $5.5M

Table 7. Biotech startups in New York, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 44 13% $1.1B
2025 50 14% $720.5M
2024 35 10% $1.1B
2023 32 9% $379.0M
2022 31 9% $189.2M
2021 49 14% $1.4B

Table 8. Biotech startups in New York, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 64 19%
2020 to 2022 72 21%
2015 to 2019 117 34%
2010 to 2014 60 18%
Before 2010 27 8%

Table 9. Biotech startups in New York, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 179 53%
11 to 50 128 38%
51 to 100 15 4%
101 to 250 11 3%
251 to 500 4 1%
1,001 to 5,000 2 1%
5,001 to 10,000 1 0%

Table 10. Biotech startups in New York, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in New York, United States are on the list?
350, in the file dated 16 November 2026. 55 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 350 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in New York, United States: 350 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in New York, United States by funding stage

Other sectors in New York

Biotech startups elsewhere

Cite: FundingWatcher, 350 funded biotech companies in New York, United States, 16 November 2026. https://fundingwatcher.com/startups/biotech/new-york-united-states/